Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer

Published:2021-03-01 Issue:3 Volume:7 Page:412
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Wang Lin¹²,Paller Channing J.³,Hong Hwanhee⁴⁵,De Felice Anthony³,Alexander G. Caleb¹²,Brawley Otis¹³

Affiliation:

1. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

2. Center for Drug Safety and Effectiveness, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

3. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland

4. Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina

5. Duke Clinical Research Institute, Duke University, Durham, North Carolina

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2774870/jamaoncology_wang_2021_oi_200103_1615397490.23946.pdf

Reference45 articles.

1. Non-metastatic castration resistant prostate cancer: a review of current and emerging medical therapies.;Alpajaro;Prostate Cancer Prostatic Dis,2019

2. Metastatic prostate cancer.;Sartor;N Engl J Med,2018

3. Chemohormonal therapy in metastatic hormone–sensitive prostate cancer.;Sweeney;N Engl J Med,2015

4. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.;James;Lancet,2016

5. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer.;Fizazi;N Engl J Med,2017

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world prevalence of adverse events with first‐line systemic therapies among patients with metastatic castration‐sensitive prostate cancer;The Prostate;2024-08-20

2. Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization;Biomolecules and Biomedicine;2024-08-16

3. Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review;Current Medicinal Chemistry;2024-08

4. Japanese clinical practice guidelines for prostate cancer 2023;International Journal of Urology;2024-07-30

5. Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study;International Journal of Urology;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3